Sjögren's syndrome pathophysiology
|
Sjögren's syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Sjögren's syndrome pathophysiology On the Web |
|
American Roentgen Ray Society Images of Sjögren's syndrome pathophysiology |
|
Risk calculators and risk factors for Sjögren's syndrome pathophysiology |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farbod Zahedi Tajrishi, M.D.
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
ُSjögren's syndrome is a chronic auto-immune disorder that can affect several organ systems. Both genetic and immune factors contribute to the pathogenesis of the disease. Lymphocytes infiltrate the lacrimal and salivary glands and impair their function, hence causing the main characteristic symptoms of the disease- dry mouth (keratoconjunctivitis sicca) and eyes (xerostomia). CD4+ T-cells are predominant in mild and moderate salivary gland infiltrations, while B cells play the major role in severe lesions [1].
Pathophysiology
The pathogenesis of Sjögren's syndrome can be linked to both genetic and nongenetic components [2].
- Genetic components:
Although multiple genes are found to be associated with ُSjögren's syndrome, evidence suggests genes that encode Major Histocompatibility Complex (MHC), particularly HLA genes, play an important role in the disease.
- Immune-mediated components:
References
- ↑ Christodoulou MI, Kapsogeorgou EK, Moutsopoulos HM (2010). "Characteristics of the minor salivary gland infiltrates in Sjögren's syndrome". J Autoimmun. 34 (4): 400–7. doi:10.1016/j.jaut.2009.10.004. PMID 19889514.
- ↑ Mavragani CP, Nezos A, Moutsopoulos HM (2013). "New advances in the classification, pathogenesis and treatment of Sjogren's syndrome". Curr Opin Rheumatol. 25 (5): 623–9. doi:10.1097/BOR.0b013e328363eaa5. PMID 23846338.